Results 211 to 220 of about 67,273 (233)

Venetoclax-Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview. [PDF]

Cancer Rep (Hoboken)
Du Y, Hassani MA, Li C, Zhao Z, Liu Y, Zhang C, Yan J.   +6 more
europepmc   +1 more source

Toward therapeutic development for ML-DS. [PDF]

Blood Adv
Tomizawa D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia

Journal of Oncology Pharmacy Practice, 2022
Wenhui Li, Katherine A Richter, Timothy Kubal   +2 more
exaly  

Assessment of graphite electrode on the removal of anticancer drug cytarabine via indirect electrochemical oxidation process: Kinetics & pathway study

Chemosphere, 2020
Alok Sinha
exaly  

Cytarabine ears – A side effect of cytarabine therapy

Journal of Oncology Pharmacy Practice, 2020
Divya Doval, Sanjeev Kumar Sharma, Vipin Khandelwal   +2 more
exaly  

Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines

International Journal of Biological Macromolecules, 2022
Krishnapriya Raji Sathyan, Sajeevan Thavarool Puthiyedathu   +1 more
exaly  

Degradation of antineoplastic cytarabine in aqueous solution by gamma radiation

Chemical Engineering Journal, 2011
M Sánchez-Polo, Jesus J López-Peñalver, Roberto Leyva-Ramos   +2 more
exaly  

Degradation of antineoplastic cytarabine in aqueous phase by advanced oxidation processes based on ultraviolet radiation

Chemical Engineering Journal, 2010
M Sánchez-Polo, Roberto Leyva-Ramos
exaly  

Clinical Pharmacokinetics of Cytarabine Formulations

Clinical Pharmacokinetics, 2012
Takeo Kawaguchi
exaly